Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -25.282% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) CSc1nc(-c2ccc(F)cc2)cc(=O)[nH]1
(b) O=S(=O)(NCCC1=CCCCC1)c1ccc(OC(F)(F)F)cc1
(c) N#C/C(=C(/O)CN1CCN(c2ccccc2F)CC1)c1nc(-c2ccccc2)cs1
(d) CCCCCCNc1nc(NCc2ccco2)nc(OCC)n1
Answer: b. O=S(=O)(NCCC1=CCCCC1)c1ccc(OC(F)(F)F)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=S(=O)(NCCC1=CCCCC1)c1ccc(OC(F)(F)F)cc1
O=S(=O)(NCCC1=CCCCC1)c1ccc(OC(F)(F)F)cc1
N-[2-(cyclohexen-1-yl)ethyl]-4-(trifluoromethoxy)benzenesulfonamide